awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33385670-C344020A-2A79-497A-B81D-E6BBB570A68F
Q33385670-C344020A-2A79-497A-B81D-E6BBB570A68F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33385670-C344020A-2A79-497A-B81D-E6BBB570A68F
Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non-Hodgkin lymphoma
P2860
Q33385670-C344020A-2A79-497A-B81D-E6BBB570A68F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33385670-C344020A-2A79-497A-B81D-E6BBB570A68F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0e28dd1e7d44e0f6cf6917629ba8c12b9002b3df
P2860
Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma.